These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 10459745)

  • 1. A case of seizures 1 week after the cessation of interferon-alpha therapy.
    Seno H; Inagaki T; Itoga M; Miyaoka T; Ishino H
    Psychiatry Clin Neurosci; 1999 Jun; 53(3):417-20. PubMed ID: 10459745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased serum soluble IL-2 receptor levels following interferon therapy in patients with chronic hepatitis C.
    Sugimura T; Motomura S; Sakai H; Nawata H
    Hepatogastroenterology; 1999; 46(27):1827-30. PubMed ID: 10430354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of prolonged interferon therapy for patients with chronic hepatitis C with HCV-genotype 1b and high virus load.
    Arase Y; Ikeda K; Tsubota A; Suzuki Y; Saitoh S; Kobayashi M; Kobayashi M; Suzuki F; Akuta N; Someya T; Kumada H
    J Gastroenterol; 2003; 38(2):158-63. PubMed ID: 12640530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
    Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
    Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot study of combination therapy with initial high-dose interferon and amantadine hydrochloride for patients with chronic hepatitis C with the genotype 1b virus.
    Uyama H; Enomoto H; Kishima Y; Yamamoto M; Yoshida K; Okuda Y; Hirotani T; Kuroda T; Ito H; Matsuda M; Terabayashi M; Noguchi S; Kawase I; Nakamura H
    Hepatogastroenterology; 2003; 50(54):2112-6. PubMed ID: 14696476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Seizures during the treatment with interferon for chronic C hepatitis].
    Anton C; Trifan A; Stanciu C; Stanciu GO; Malgarinos G
    Rev Med Chir Soc Med Nat Iasi; 2000; 104(2):135-7. PubMed ID: 12089978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of myasthenia gravis which developed myasthenic crisis after alpha-interferon therapy for chronic hepatitis C].
    Konishi T
    Rinsho Shinkeigaku; 1996 Aug; 36(8):980-5. PubMed ID: 8958752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term interferon therapy for chronic hepatitis C patients with low viral load.
    Sato Y; Tokuue H; Kawamura N; Nezu-Yajima S; Nakajima H; Ishida H; Takahashi S
    Hepatogastroenterology; 2004; 51(58):968-72. PubMed ID: 15239226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy with transarterial chemoembolization and interferon-alpha compared with transarterial chemoembolization alone for hepatitis B virus related unresectable hepatocellular carcinoma.
    Li M; Lu C; Cheng J; Zhang J; Cao C; Xu J; Xu J; Pan H; Zhong B; Tucker S; Wang D
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1437-44. PubMed ID: 19486255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Parkinsonism in a patient receiving interferon alpha therapy for chronic hepatitis C].
    Mizoi Y; Kaneko H; Oharazawa A; Kuroiwa H
    Rinsho Shinkeigaku; 1997 Jan; 37(1):54-6. PubMed ID: 9146076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daily interferon therapy for chronic hepatitis C: a report of a community practice experience.
    Srinivas D; Mani H; Crumpler C; Van Thiel DH
    Hepatogastroenterology; 2002; 49(46):1053-7. PubMed ID: 12143200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depressive symptoms after initiation of interferon therapy in human immunodeficiency virus-infected patients with chronic hepatitis C.
    Laguno M; Blanch J; Murillas J; Blanco JL; León A; Lonca M; Larrousse M; Biglia A; Martinez E; García F; Miró JM; de Pablo J; Gatell JM; Mallolas J
    Antivir Ther; 2004 Dec; 9(6):905-9. PubMed ID: 15651749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Phase I/II study evaluating escalating doses of recombinant human albumin-interferon-alpha fusion protein in chronic hepatitis C patients who have failed previous interferon-alpha-based therapy.
    Balan V; Nelson DR; Sulkowski MS; Everson GT; Lambiase LR; Wiesner RH; Dickson RC; Post AB; Redfield RR; Davis GL; Neumann AU; Osborn BL; Freimuth WW; Subramanian GM
    Antivir Ther; 2006; 11(1):35-45. PubMed ID: 16518958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyponatremia-induced seizure during carbamazepine treatment.
    Holtschmidt-Täschner B; Soyka M
    World J Biol Psychiatry; 2007; 8(1):51-3. PubMed ID: 17366352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Administration of interferon-alpha during pregnancy: effects on fetus.
    Hiratsuka M; Minakami H; Koshizuka S; Sato I
    J Perinat Med; 2000; 28(5):372-6. PubMed ID: 11125927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Is combination therapy of chronic hepatitis C with interferon alpha and ribavirin in primary interferon nonresponders indicated?--An analysis of personal experiences and review of the literature].
    Wedemeyer H; Jäckel E; Wedemeyer J; Frank H; Schüler A; Trautwein C; Manns MP
    Z Gastroenterol; 1998 Sep; 36(9):819-27. PubMed ID: 9795411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of two interferon alfa treatment regimens characterized by an early virological response in patients with chronic hepatitis C.
    Kagawa T; Hosoi K; Takashimizu S; Kawazoe K; Mochizuki K; Wasada M; Nagata N; Uchiyama J; Nakano A; Nishizaki Y; Watanabe N; Matsuzaki S
    Am J Gastroenterol; 1998 Feb; 93(2):192-6. PubMed ID: 9468240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined therapy with interferon and low-dose ribavirin in posttransplantation recurrent hepatitis C: a pragmatic study.
    Alberti AB; Belli LS; Airoldi A; de Carlis L; Rondinara G; Minola E; Vangeli M; Cernuschi A; D'Amico M; Forti D; Pinzello G
    Liver Transpl; 2001 Oct; 7(10):870-6. PubMed ID: 11679985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronic hepatitis C--therapeutic modalities for interferon failure].
    Hermann R
    Praxis (Bern 1994); 1998 Oct; 87(42):1413-20. PubMed ID: 9824949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind, placebo-controlled dose-escalation trial of merimepodib (VX-497) and interferon-alpha in previously untreated patients with chronic hepatitis C.
    McHutchison JG; Shiffman ML; Cheung RC; Gordon SC; Wright TL; Pottage JC; McNair L; Ette E; Moseley S; Alam J
    Antivir Ther; 2005; 10(5):635-43. PubMed ID: 16152757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.